These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 2016716)
1. Synthesis of potential dual-acting radiation sensitizer antineoplastic agents: 2,2-dimethylphosphoraziridines containing 2-nitroimidazoles or other electron-affinic moieties. Perlman ME; Dunn JA; Piscitelli TA; Earle J; Rose WC; Wampler GL; MacDiarmid JE; Bardos TJ J Med Chem; 1991 Apr; 34(4):1400-7. PubMed ID: 2016716 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and testing of quinone-based bis(2,2-dimethyl-1-aziridinyl)phosphinyl carbamates as radiation-potentiating antitumor agents. Zhang SF; Earle J; MacDiarmid J; Bardos TJ J Med Chem; 1988 Jun; 31(6):1240-4. PubMed ID: 3373492 [TBL] [Abstract][Full Text] [Related]
3. Synthesis of new nucleoside phosphoraziridines as potential site-directed antineoplastic agents. Breiner RG; Rose WC; Dunn JA; MacDiarmid JE; Bardos TJ J Med Chem; 1990 Sep; 33(9):2596-602. PubMed ID: 2391698 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and properties of bis(2,2-dimethylaziridinyl)phosphinic amides: a series of new antineoplastic agents. MacDiarmid JE; Rose WC; Biddle WC; Perlman ME; Breiner RG; Ambrus JL; Bardos TJ J Med Chem; 1985 Nov; 28(11):1685-91. PubMed ID: 4067995 [TBL] [Abstract][Full Text] [Related]
5. A new class of analogues of the bifunctional radiosensitizer alpha-(1-aziridinylmethyl)-2-nitro-1H-imidazole-1-ethanol (RSU 1069): the cycloalkylaziridines. Suto MJ; Stier MA; Werbel LM; Arundel-Suto CM; Leopold WR; Elliott WE; Sebolt-Leopold JS J Med Chem; 1991 Aug; 34(8):2484-8. PubMed ID: 1875345 [TBL] [Abstract][Full Text] [Related]
6. Electron-affinic radiosensitizers possessing NPSH-reactive side chains: cytotoxicity and radiosensitizing activity towards hypoxic EMT6 cells in vitro. Zhou L; Nishimoto S Int J Radiat Biol; 1995 Mar; 67(3):335-46. PubMed ID: 7897282 [TBL] [Abstract][Full Text] [Related]
8. Hypoxia-selective antitumor agents. 10. bis(nitroimidazoles) and related Bis(nitroheterocycles): development of derivatives with higher rates of metabolic activation under hypoxia and improved aqueous solubility. Hay MP; Lee HH; Wilson WR; Roberts PB; Denny WA J Med Chem; 1995 May; 38(11):1928-41. PubMed ID: 7783125 [TBL] [Abstract][Full Text] [Related]
9. Misonidazole and MTDQ in combination: cytotoxic and radiosensitizing properties in hypoxic mammalian cells. Astor M; Hall EJ Br J Cancer; 1979 May; 39(5):510-5. PubMed ID: 486306 [TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo radiosensitization by 2-nitroimidazoles more electron-affinic than misonidazole. Brown DM; Yu NY; Brown JM; Lee WW Int J Radiat Oncol Biol Phys; 1982; 8(3-4):435-8. PubMed ID: 7107364 [TBL] [Abstract][Full Text] [Related]
11. 2-Nitroimidazole dual-function bioreductive drugs: studies on the effects of regioisomerism and side-chain structural modifications on differential cytotoxicity and radiosensitization by aziridinyl and oxiranyl derivatives. Naylor MA; Threadgill MD; Webb P; Stratford IJ; Stephens MA; Fielden EM; Adams GE J Med Chem; 1992 Sep; 35(19):3573-8. PubMed ID: 1404237 [TBL] [Abstract][Full Text] [Related]
12. Hypoxia-selective antitumor agents. 8. Bis(nitroimidazolyl)alkanecarboxamides: a new class of hypoxia-selective cytotoxins and hypoxic cell radiosensitisers. Hay MP; Wilson WR; Moselen JW; Palmer BD; Denny WA J Med Chem; 1994 Feb; 37(3):381-91. PubMed ID: 8308864 [TBL] [Abstract][Full Text] [Related]
13. Synthfsis of bis(aziridinyl)phosphinyl-N-hydroxyurethane derivatives as antineoplastic agents. Hsiao YY; Bardos TJ; Wampler GL; Regelson W J Med Chem; 1975 Feb; 18(2):195-8. PubMed ID: 1120987 [TBL] [Abstract][Full Text] [Related]
15. New antimetastatic hypoxic cell radiosensitizers: design, synthesis, and biological activities of 2-nitroimidazole-acetamide, TX-1877, and its analogues. Kasai S; Nagasawa H; Yamashita M; Masui M; Kuwasaka H; Oshodani T; Uto Y; Inomata T; Oka S; Inayama S; Hori H Bioorg Med Chem; 2001 Feb; 9(2):453-64. PubMed ID: 11249137 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of a series of 3,5-disubstituted benzisoxazole-4,7-diones. Potent radiosensitizers in vitro. Suto MJ; Stier MA; Winters RT; Turner WR; Pinter CD; Elliott WE; Sebolt-Leopold JS J Med Chem; 1991 Nov; 34(11):3290-4. PubMed ID: 1956048 [TBL] [Abstract][Full Text] [Related]
19. In vivo evaluation of the radiosensitizing and cytotoxic properties of newly synthesized electron-affinic drugs. Brown JM; Yu NY; Cory MJ; Bicknell RB; Taylor DL Br J Cancer Suppl; 1978 Jun; 3():206-11. PubMed ID: 277229 [TBL] [Abstract][Full Text] [Related]
20. [Synthesis of 1-substituted nitroimidazoles and its evaluation as radiosensitizing agents]. Adams DR; Martul R; Alvarez MV; López Zumel MC; Espada M Acta Cient Venez; 1991; 42(5):257-65. PubMed ID: 1843567 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]